Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Myelin Protein Zero-Like 1 (MPZL1) (Middle Region) Peptid

MPZL1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN980222

Kurzübersicht für Myelin Protein Zero-Like 1 (MPZL1) (Middle Region) Peptid (ABIN980222)

Target

MPZL1 (Myelin Protein Zero-Like 1 (MPZL1))

Spezies

Human

Quelle

  • 1
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-MPZL1 antibody (Catalog #: ARP46390_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    MPZL1 (Myelin Protein Zero-Like 1 (MPZL1))

    Hintergrund

    MPZL1 is a cell surface receptor, which is involved in signal transduction processes. MPZL1 recruits PTPN11/SHP-2 to the cell membrane and is a putative substrate of PTPN11/SHP-2. MPZL1 is a major receptor for concanavalin A (ConA) and is involved in cell

    Alias Symbols: FLJ21047, PZR, PZR1b, PZRa, PZRb, MPZL1b

    Protein Interaction Partner: EXOSC4,PTPN11,SRC,PTPN11,SRC

    Protein Size: 209

    Molekulargewicht

    23 kDa

    Gen-ID

    9019

    NCBI Accession

    NM_024569, NP_078845
Sie sind hier:
Chat with us!